• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 的死亡率和生存率。

Mortality and survival of COVID-19.

机构信息

Postgraduation Program in Clinical Care in Nursing and Health, Ceará State University, Fortaleza, Ceará, Brazil.

出版信息

Epidemiol Infect. 2020 Jun 25;148:e123. doi: 10.1017/S0950268820001405.

DOI:10.1017/S0950268820001405
PMID:32580809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7330281/
Abstract

This study aims to identify the risk factors associated with mortality and survival of COVID-19 cases in a state of the Brazilian Northeast. It is a historical cohort with a secondary database of 2070 people that presented flu-like symptoms, sought health assistance in the state and tested positive to COVID-19 until 14 April 2020, only moderate and severe cases were hospitalised. The main outcome was death as a binary variable (yes/no). It also investigated the main factors related to mortality and survival of the disease. Time since the beginning of symptoms until death/end of the survey (14 April 2020) was the time variable of this study. Mortality was analysed by robust Poisson regression, and survival by Kaplan-Meier and Cox regression. From the 2070 people that tested positive to COVID-19, 131 (6.3%) died and 1939 (93.7%) survived, the overall survival probability was 87.7% from the 24th day of infection. Mortality was enhanced by the variables: elderly (HR 3.6; 95% CI 2.3-5.8; P < 0.001), neurological diseases (HR 3.9; 95% CI 1.9-7.8; P < 0.001), pneumopathies (HR 2.6; 95% CI 1.4-4.7; P < 0.001) and cardiovascular diseases (HR 8.9; 95% CI 5.4-14.5; P < 0.001). In conclusion, mortality by COVID-19 in Ceará is similar to countries with a large number of cases of the disease, although deaths occur later. Elderly people and comorbidities presented a greater risk of death.

摘要

本研究旨在确定与巴西东北部 COVID-19 病例死亡率和存活率相关的风险因素。这是一项历史队列研究,使用了 2070 名出现流感样症状、在该州寻求医疗救助并经检测 COVID-19 呈阳性的人的二级数据库,直至 2020 年 4 月 14 日,仅中度和重度病例住院。主要结局是死亡,为二分类变量(是/否)。还调查了与疾病死亡率和存活率相关的主要因素。从症状开始到死亡/调查结束(2020 年 4 月 14 日)的时间是本研究的时间变量。死亡率采用稳健泊松回归分析,存活率采用 Kaplan-Meier 和 Cox 回归分析。在 2070 名 COVID-19 检测呈阳性的人中,有 131 人(6.3%)死亡,1939 人(93.7%)存活,感染第 24 天的总体存活率为 87.7%。死亡率增加的变量有:老年人(HR 3.6;95%CI 2.3-5.8;P < 0.001)、神经系统疾病(HR 3.9;95%CI 1.9-7.8;P < 0.001)、肺炎(HR 2.6;95%CI 1.4-4.7;P < 0.001)和心血管疾病(HR 8.9;95%CI 5.4-14.5;P < 0.001)。总之,塞阿拉州的 COVID-19 死亡率与有大量病例的国家相似,尽管死亡发生较晚。老年人和合并症的死亡风险更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eb1/7330281/64569b3d8c94/S0950268820001405_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eb1/7330281/fccbe6b96a93/S0950268820001405_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eb1/7330281/64569b3d8c94/S0950268820001405_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eb1/7330281/fccbe6b96a93/S0950268820001405_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eb1/7330281/64569b3d8c94/S0950268820001405_fig2.jpg

相似文献

1
Mortality and survival of COVID-19.COVID-19 的死亡率和生存率。
Epidemiol Infect. 2020 Jun 25;148:e123. doi: 10.1017/S0950268820001405.
2
Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil.巴西一项回顾性多中心队列研究中 COVID-19 住院患者死亡的生存情况及其预测因素。
Epidemiol Infect. 2020 Sep 7;148:e198. doi: 10.1017/S0950268820002034.
3
Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil.在巴西,慢性心脏病是新冠病毒病死亡病例中最常见的合并症。
Rev Inst Med Trop Sao Paulo. 2020 Jun 29;62:e45. doi: 10.1590/S1678-9946202062045. eCollection 2020.
4
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
5
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.COVID-19 呼吸衰竭的 CPAP 管理:来自住院服务评估的首次定量分析。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000692.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉 COVID-19 卒中患者的临床病程和死亡率。
Stroke. 2020 Sep;51(9):2674-2682. doi: 10.1161/STROKEAHA.120.030642. Epub 2020 Jul 31.
8
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study.巴西 COVID-19 住院死亡率的种族和地区差异:一项横断面观察性研究。
Lancet Glob Health. 2020 Aug;8(8):e1018-e1026. doi: 10.1016/S2214-109X(20)30285-0. Epub 2020 Jul 2.
9
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
10
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.

引用本文的文献

1
Statistical learning methods for improving predictive performance in time-dependent survival models.用于提高时间相依生存模型预测性能的统计学习方法。
Genomics Inform. 2025 Sep 1;23(1):19. doi: 10.1186/s44342-025-00050-7.
2
A Bayesian Survival Analysis on Long COVID and Non-Long COVID Patients: A Cohort Study Using National COVID Cohort Collaborative (N3C) Data.长新冠患者与非长新冠患者的贝叶斯生存分析:一项使用国家新冠队列协作组(N3C)数据的队列研究
Bioengineering (Basel). 2025 May 7;12(5):496. doi: 10.3390/bioengineering12050496.
3
Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile.

本文引用的文献

1
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素:基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
2
Covid-19: risk factors for severe disease and death.新冠病毒病:重症和死亡的风险因素
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
3
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
智利一个社区医疗网络中,SARS-CoV-2感染的人口统计学、临床特征与严重并发症之间的关联。
PLoS One. 2024 Dec 30;19(12):e0314376. doi: 10.1371/journal.pone.0314376. eCollection 2024.
4
Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study.埃塞俄比亚霍拉萨尼医院 COVID-19 患者的生存情况:一项队列研究。
BMC Infect Dis. 2024 Sep 27;24(1):1055. doi: 10.1186/s12879-024-09905-w.
5
Relevance of Mediterranean diet as a nutritional strategy in diminishing COVID-19 risk: A systematic review.地中海饮食作为降低 COVID-19 风险的营养策略的相关性:系统评价。
PLoS One. 2024 Aug 21;19(8):e0301564. doi: 10.1371/journal.pone.0301564. eCollection 2024.
6
The effect of adaptive capacity on resilience to the COVID-19 pandemic: A cross-country analysis.适应能力对新冠疫情恢复力的影响:一项跨国分析。
Jamba. 2024 Jul 25;16(1):1697. doi: 10.4102/jamba.v16i1.1697. eCollection 2024.
7
A Bayesian Survival Analysis on Long COVID and non Long COVID patients: A Cohort Study Using National COVID Cohort Collaborative (N3C) Data.一项关于长期新冠患者和非长期新冠患者的贝叶斯生存分析:一项使用国家新冠队列协作组(N3C)数据的队列研究。
medRxiv. 2024 Jun 25:2024.06.25.24309478. doi: 10.1101/2024.06.25.24309478.
8
COVID-19 mortality rate and its determinants in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚的新冠病毒疾病死亡率及其决定因素:一项系统综述与荟萃分析
Front Med (Lausanne). 2024 Feb 27;11:1327746. doi: 10.3389/fmed.2024.1327746. eCollection 2024.
9
Time to death and its predictors among adult patients with COVID-19: A retrospective cohort study in Ethiopia.新冠病毒病成年患者的死亡时间及其预测因素:埃塞俄比亚的一项回顾性队列研究
Front Epidemiol. 2023 Jan 17;2:1065184. doi: 10.3389/fepid.2022.1065184. eCollection 2022.
10
Demographic study of patients' mortality rate before and after the COVID-19 outbreak: A cross-sectional study.新冠疫情爆发前后患者死亡率的人口统计学研究:一项横断面研究。
Health Sci Rep. 2024 Feb 8;7(2):e1845. doi: 10.1002/hsr2.1845. eCollection 2024 Feb.
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
4
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
5
Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.宿主对重症新型冠状病毒肺炎的易感性及宿主风险评分的建立:武汉以外地区487例病例的研究结果
Crit Care. 2020 Mar 18;24(1):108. doi: 10.1186/s13054-020-2833-7.
6
Real estimates of mortality following COVID-19 infection.新冠病毒感染后死亡率的实际估计值。
Lancet Infect Dis. 2020 Jul;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. Epub 2020 Mar 12.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
9
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.2019新型冠状病毒感染右删失情况下的潜伏期及其他流行病学特征:基于公开病例数据的统计分析
J Clin Med. 2020 Feb 17;9(2):538. doi: 10.3390/jcm9020538.
10
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病(COVID-19)疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.